Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 7, 2013, Pages 794-803

  Boberg, K M ^a,b   Wisloff T ^c   Kjollesdal K S ^d   Stovring H ^e   Kristiansen, I S ^f  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e AARHUS UNIVERSITY   (Denmark)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; CANADA; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; LIFE EXPECTANCY; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MARKOV CHAINS; MIDDLE AGED; NORWAY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; TIME FACTORS; URSODEOXYCHOLIC ACID;

EID: 84883489249     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12435     Document Type: Article

References (28)

1. Kaplan MM,. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570-80.
2. Prince M, Chetwynd A, Newman W, Metcalf JV, James OF,. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 2002; 123: 1044-51.
3. Heathcote EJ, Cauch-Dudek K, Walker V, et al,. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19: 1149-56.
4. Lindor KD, Dickson ER, Baldus WP, et al,. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 1284-90.
5. Pares A, Caballeria L, Rodes J, et al,. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver. J Hepatol 2000; 32: 561-6.
6. Poupon RE, Poupon R, Balkau B,. Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. N Engl J Med 1994; 330: 1342-7.
7. Poupon RE, Lindor KD, Cauch-Dudek K, et al,. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997; 113: 884-90.
8. Gong Y, Huang Z, Christensen E, Gluud C,. Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses. Am J Gastroenterol 2007; 102: 1799-807.
9. Goulis J, Leandro G, Burroughs AK,. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 1999; 354: 1053-60.
10. Gluud C, Christensen E,. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev 2002; CD000551.
11. Shi J, Wu C, Lin Y, et al,. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2006; 101: 1529-38.
12. Poupon RE,. Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past-issues for the future. J Hepatol 2000; 32: 685-8.
13. Lindor KD, Gershwin ME, Poupon R, et al,. Primary biliary cirrhosis. Hepatology 2009; 50: 291-308.
14. EASL. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237-67.
15. Pasha T, Heathcote J, Gabriel S, et al,. Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis. Hepatology 1999; 29: 21-6.
16. Angulo P, Lindor KD, Therneau TM, et al,. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver 1999; 19: 115-21.
17. Sonnenberg FA, Beck JR,. Markov models in medical decision making: a practical guide. Med Decis Making 1993; 13: 322-38.
18. Briggs AH, Claxton K, Sculpher M,. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press, 2006.
19. Wright JC, Weinstein MC,. Gains in life expectancy from medical interventions-standardizing data on outcomes. N Engl J Med 1998; 339: 380-6.
20. Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER,. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 1996; 110: 1515-8.
21. Olsson R, Boberg KM, de Muckadell OS, et al,. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 2005; 129: 1464-72.
22. Angulo P, Dickson ER, Therneau TM, et al,. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. J Hepatol 1999; 30: 830-5.
23. Corpechot C, Carrat F, Bahr A, et al,. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 2005; 128: 297-303.
24. Locke GR III, Therneau TM, Ludwig J, Dickson ER, Lindor KD,. Time course of histological progression in primary biliary cirrhosis. Hepatology 1996; 23: 52-6.
25. Siebert U, Alagoz O, Bayoumi AM, et al,. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Making 2012; 32: 690-700.
26. Pares A, Caballeria L, Rodes J,. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology 2006; 130: 715-20.
27. Corpechot C, Abenavoli L, Rabahi N, et al,. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 2008; 48: 871-7.
28. Carithers RL Jr,. Primary biliary cirrhosis: specific treatment. Clin Liver Dis 2003; 7: 923-39.